Login to Your Account



Abbott Gains Broad Access To PDL's Antibody Technology

By Kim Coghill


Tuesday, June 8, 2004
Protein Design Labs Inc. and Abbott Laboratories entered a long-term agreement that gives Abbott broad access to PDL's technology for antibody humanization. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription